Lynd, Larry D.; Goeree, Ron; O'Brien, Bernie J. - In: PharmacoEconomics 23 (2005) 11, pp. 1083-1106
, zanamivir and oseltamivir. The objective of this paper was to review the studies evaluating the cost effectiveness of currently … incremental cost-effectiveness ratios (ICERs) for antiviral treatment strategies ranged from $US5000/QALY for amantadine in test … consistently reported a strong influence of the population prevalence or diagnostic accuracy of influenza on the cost effectiveness …